Paratek Pharmaceuticals, Inc. (PRTK): Price and Financial Metrics

Paratek Pharmaceuticals, Inc. (PRTK)

Today's Latest Price: $3.07 USD

0.07 (2.33%)

Updated Dec 6 2:50pm

Add PRTK to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 325 in Biotech

See all "A" rated Strong Buy stocks

PRTK Stock Summary

  • Paratek Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 4.64% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 10.85 for Paratek Pharmaceuticals Inc; that's greater than it is for 94.55% of US stocks.
  • Revenue growth over the past 12 months for Paratek Pharmaceuticals Inc comes in at 303.37%, a number that bests 98% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Paratek Pharmaceuticals Inc are YY, INSM, RDUS, RNWK, and KALA.
  • Visit PRTK's SEC page to see the company's official filings. To visit the company's web site, go to
PRTK Daily Price Range
PRTK 52-Week Price Range

PRTK Stock Price Chart More Charts

PRTK Price/Volume Stats

Current price $3.07
Prev. close $3.00
Day low $2.98
Day high $3.19
50-day MA $3.45
200-day MA $4.38
52-week high $7.39
52-week low $2.66
Volume 668,048
Avg. volume 401,702
Dividend yield N/A
Market Cap 102.19M

Paratek Pharmaceuticals, Inc. (PRTK) Company Bio

Paratek Pharmaceuticals focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. The company was founded in 1996 and is based in in Boston, Massachusetts.

PRTK Latest News Stream

Event/Time News Detail
Loading, please wait...

PRTK Latest Social Stream

Loading social stream, please wait...

View Full PRTK Social Stream

PRTK Price Returns

1-mo -24.38%
3-mo -21.08%
6-mo -15.89%
1-year -57.00%
3-year -77.51%
5-year -82.20%
YTD -40.16%
2018 -71.34%
2017 16.23%
2016 -18.82%
2015 -50.79%
2014 139.99%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.606 seconds.